Page 54 - MONOGRAFIA 25, de Esclerosis multiple

FACTORES AMBIENTALES
DE LA ESCLEROSIS MÚLTIPLE
54
BIBLIOGRAFÍA
1. Pierrot-Deseilligny C, Souberbielle J-C. Vitamin D and multiple sclerosis: an update. Mult Scler Relat Disord. 2017;14:35-45.
2. Bikle DD. Vitamin D Metabolism, Mechanism of Action, and Clinical Applications. Chem Biol. 2014;21:319-29.
3. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010;9:599-612. 4. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune
system. Curr Opin Pharmacol. 2010;10:482-96.
5. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in
multiple sclerosis, a review. J Neuroimmunol. 2008;194:7-17.
6. Shahijanian F, Parnell GP, McKay FC, Gatt PN, Shojoei M, O’Connor KS, et al. The CYP27B1
variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing
dendritic cells. Hum Mol Genet. 2014;23:1425-34.
7. Hallau J, Hamann L, Schumann RR, Worm M, Heine G. A Promoter Polymorphism of the
Vitamin D Metabolism Gene Cyp24a1 is Associated with Severe Atopic Dermatitis in Adults. Acta
Derm Venereol. 2016;96:169-72.
8. Salzer J, Nyström M, Hallmans G, Stenlund H, Wadell G, Sundström P. Epstein-Barr virus antibodies
and vitamin D in prospective multiple sclerosis biobank samples. Mult Scler. 2013;19:1587-91.
9. Nejati A, Shoja Z, Shahmahmoodi S, Tafakhori A, Mollaei-Kandelous Y, Rezaei F, et al. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Med Microbiol Immunol (Berl). 2016;205:143-54.
10. Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, et al. Effect
of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in
relapsing-remitting multiple sclerosis. Mult Scler. 2017;23:395-402.
11. Hayes CE, Donald Acheson E. A unifying multiple sclerosis etiology linking virus infection,
sunlight, and vitamin D, through viral interleukin-10. Med Hypotheses. 2008;71:85-90.
12. Ricigliano VAG, Handel AE, Sandve GK, Annibali V, Ristori G, Mechelli R, et al. EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor
Occupancy. PLoS One. 2015;10:e0119605.
13. Yenamandra SP, Hellman U, Kempkes B, Darekar SD, Petermann S, Sculley T, et al. Epstein-Barr
virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell
Mol Life Sci. 2010;67:4249-56.
14. Mostafa A, Jalilvand S, Shoja Z, Nejati A, Shahmahmoodi S, Sahraian MA, et al. Multiple sclerosis-
associated retrovirus, Epstein-Barr virus, and vitamin D status in patients with relapsing remitting
multiple sclerosis. J Med Virol. 2017;89:1309-13.
15. Wang J, Thingholm LB, Skieceviciene J, Rausch P, Kummen M, Hov JR, et al. Genome-wide
association analysis identifies variation in vitamin D receptor and other host factors influencing the
gut microbiota. Nat Genet. 2016;48:1396-406.
16. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and
risk of multiple sclerosis. JAMA. 2006;296:2832-8.
17. Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P. Vitamin D as a protective
factor in multiple sclerosis. Neurology. 2012;79:2140-5.